<DOC>
	<DOCNO>NCT00454441</DOCNO>
	<brief_summary>Menopausal woman often complain difficulty sleep transition pre- postmenopausal status associate incresase self-reported sleep disturbance . Hot flash associate self-reported measure sleep disturbance change sleep pattern measure plysomnography , include increase stage 4 latency shorten time rapid-eye movement sleep . Although data effect hormone replacement therapy self-reported sleep measure symptomatic postmenopausal woman , data effect herbal extract subjective objective measure sleep quality population group . Actigraphy , use device record movement generally place wrist , use 20 year provide objective data concern sleep/wake pattern . The advantage actigraphy traditional polysomnography actigraphy conveniently record continuously 24-hours day long period time .</brief_summary>
	<brief_title>Sleep Quality CHIMES ( MF101 )</brief_title>
	<detailed_description>Specific Aims : 1 . To determine effect MF101 ( combination Chinese herb ) compare placebo change sleep quality utilizing baseline follow-up actigraphy obtain subset approximately 90 woman enrol randomized , double-blind , placebo-controlled Chinese Herbs Menopausal Symptoms ( CHIMES ) trial . 2 . TO identify correlate sleep quality assess actigraphy woman frequent hot flash . We evaluate demographic , lifestyle , anthropometric , medical gynecologic history hormonal factor may relate actigraphic measure sleep quality , include self-reported measure sleep .</detailed_description>
	<criteria>Women age 40 60 . Currently receive medical care health care provider . Selfreport 5 hot flash per day 35 hot flash per week . Postmenopausal define 12 month spontaneous amenorrhea 6 month spontaneous amenorrhea serum FSH level &gt; 30mlU/ml 6 week postsurgical bilateral oophorectomy without hysterectomy hysterectomy FSH level &gt; 30 mlU/ml . Agree start new herbal dietary supplement change dose currently use herbal dietary supplement duration trial . Successful completion Hot Flash Diary , Daily Study Medication Diary Bleeding Diary , tolerate placebo , 80 % compliant runin . Must mammogram within last 9 month . Have access phone . Provide inform consent . Inability sign inform consent fill questionnaire . History breast , uterine ovarian cancer melanoma . Abnormal mammogram breast examination within last 9 month suggestive cancer . Abnormal Pap smear pelvic examination within last 9 month suggestive cancer . Doublewall endometrial thickness exceed 5 mm measure transvaginal ultrasound . Unexplained abnormal uterine bleeding within six month enrollment . Pregnancy lactate . Clinical evidence active ischemic cardiovascular disease history cardiovascular disease . History deep vein thrombosis pulmonary embolism require anticoagulation . Active liver gallbladder disease . Use medication , herbal dietary supplement know possibly effective treatment hot flash within three month enrollment oral transdermal drug , within 6 month enrollment implant injected drug . Use raloxifene tamoxifen within three month enrollment . Use another investigational agent within 3 month enrollment . History multiple severe food medicine allergy . Any medical psychiatric condition , investigator â€™ opinion , would preclude participant adhere protocol complete trial , include severe illness , plan move , substance abuse , significant problem , dementia .</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2007</verification_date>
	<keyword>Sleep Quality</keyword>
	<keyword>Menopausal Symptoms</keyword>
	<keyword>Actigraph</keyword>
	<keyword>Bionovo</keyword>
	<keyword>MF101</keyword>
</DOC>